A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

Inovio Pharmaceuticals ( ($INO) ) has provided an announcement. On December 29, 2025, INOVIO announced that the U.S. Food and Drug Administration ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

As we close out 2025, I am excited to reflect on a year marked by significant clinical progress, robust data validation, and strategic execution that has significantly strengthened IMUNON's position.

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Twist Biosciences Corporation is one of the most promising stocks on our list. TheFly reported on ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...

By Henry A. Onwubiko“A nation that cannot control its own seeds cannot decide its destiny.” –Captain Ibrahim Troure Genetic engineering, the manipulation of deoxyribonucleic acid (DNA), the hereditary ...

The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China ...